Elevated levels of CRP, IL-1β, IL-6 and TNF-α in patients with chronic inflammatory diseases stimulate the initiation and accelerate the progression of atherosclerosis, increasing markedly risk of CVD events [72,76]. This evidence concerns the gene IL6 and atherosclerosis.